Related references
Note: Only part of the references are listed.Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani
Pradyot Bhattacharya et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
Rebecca J. Faleiro et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14
Priscila L. dos Santos et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis
Shibabrata Mukherjee et al.
EXPERIMENTAL DERMATOLOGY (2015)
M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis
Debanjan Mukhopadhyay et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Leishmaniasis in immunosuppressed individuals
J. van Griensven et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
Eduard E. Zijlstra
PLOS NEGLECTED TROPICAL DISEASES (2014)
Immune Regulation during Chronic Visceral Leishmaniasis
Rebecca J. Faleiro et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis
Rajiv Kumar et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India
Sakib Burza et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Antimony Resistant Leishmania donovani but Not Sensitive Ones Drives Greater Frequency of Potent T-Regulatory Cells upon Interaction with Human PBMCs: Role of IL-10 and TGF-β in Early Immune Response
Rajan Guha et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Clinical and Immunological Aspects of Post-Kala-Azar Dermal Leishmaniasis in Bangladesh
Shamim Islam et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Loss and Dysregulation of Th17 Cells during HIV Infection
Sandra L. Bixler et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: A possible challenge to elimination program in India
V. N. R. Das et al.
JOURNAL OF POSTGRADUATE MEDICINE (2013)
Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern
Jyotsna Mishra et al.
PARASITOLOGY RESEARCH (2013)
Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
Sankha Koley et al.
INDIAN JOURNAL OF DERMATOLOGY (2013)
Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients
Eltahir Awad Gasim Khalil et al.
JOURNAL OF TROPICAL MEDICINE (2013)
Reassessment of Immune Correlates in Human Visceral Leishmaniasis as Defined by Cytokine Release in Whole Blood
Om Prakash Singh et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Post-Kala-Azar Dermal Leishmaniasis in a Patient Treated with Injectable Paromomycin for Visceral Leishmaniasis in India
Krishna Pandey et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India
B. V. Subba Raju et al.
PARASITOLOGY RESEARCH (2012)
Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis
Debanjan Mukhopadhyay et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2012)
Evidence for Involvement of Th17 Type Responses in Post Kala Azar Dermal Leishmaniasis (PKDL)
Gajendra Kumar Katara et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
CD8(+) T cells in Leishmania infections: friends or foes?
Simona Staeger et al.
FRONTIERS IN IMMUNOLOGY (2012)
IL-27 and IL-21 Are Associated with T Cell IL-10 Responses in Human Visceral Leishmaniasis
Nasim Akhtar Ansari et al.
JOURNAL OF IMMUNOLOGY (2011)
Miltefosine Effectively Modulates the Cytokine Milieu in Indian Post Kala-Azar Dermal Leishmaniasis
Debanjan Mukhopadhyay et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
IL-10 Neutralization Promotes Parasite Clearance in Splenic Aspirate Cells From Patients With Visceral Leishmaniasis
Shalini Gautam et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Blindness following visceral leishmaniasis: a neglected post-kala-azar complication
E. A. G. Khalil et al.
TROPICAL DOCTOR (2011)
Foxp3 and IL-10 Expression Correlates with Parasite Burden in Lesional Tissues of Post Kala Azar Dermal Leishmaniasis (PKDL) Patients
Gajendra Kumar Katara et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Immune evasive mechanisms contributing to persistent Leishmania donovani infection
Simona Staeger et al.
IMMUNOLOGIC RESEARCH (2010)
Enhanced Lesional Foxp3 Expression and Peripheral Anergic Lymphocytes Indicate a Role for Regulatory T Cells in Indian Post-Kala-Azar Dermal Leishmaniasis
Sudipto Ganguly et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Quantification of Parasite Load in Clinical Samples of Leishmaniasis Patients: IL-10 Level Correlates with Parasite Load in Visceral Leishmaniasis
Sandeep Verma et al.
PLOS ONE (2010)
Interleukin 10 Gene Polymorphisms and Development of Post Kala-Azar Dermal Leishmaniasis in a Selected Sudanese Population
S. Farouk et al.
PUBLIC HEALTH GENOMICS (2010)
A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy
Smriti Mondal et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial
Asrat Hailu et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Leishmania donovani Isolates with Antimony-Resistant but Not -Sensitive Phenotype Inhibit Sodium Antimony Gluconate-Induced Dendritic Cell Activation
Arun Kumar Haldar et al.
PLOS PATHOGENS (2010)
Immunological Perspectives of Leishmaniasis
Susanne Nylen et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major Infection
Charles F. Anderson et al.
JOURNAL OF IMMUNOLOGY (2009)
Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis
N. A. Ansari et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
The relationship between leishmaniasis and AIDS: the second 10 years
Jorge Alvar et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Diffuse cutaneous leishmaniasis: Co-infection with human immunodeficiency virus (HIV)
Raju G. Chaudhary et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2008)
Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis
Sudipto Ganguly et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis
Nasim Akhtar Ansari et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
Immunochemotherapy of persistent post-kata-azar dermal leishmaniasis: a novel approach to treatment
Ahmed Mudawi Musa et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
IL-10- and TGF-β-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis:: The significance of amphotericin B in the control of Leishmania donovani infection in India
Samiran Saha et al.
JOURNAL OF IMMUNOLOGY (2007)
Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy
Julius Lukes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan
M. A. Salih et al.
GENES AND IMMUNITY (2007)
Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major plus BCG) in children:: an extended phase II study
Eltahir Awad Gasim Khalil et al.
ANNALS OF TROPICAL PAEDIATRICS (2006)
Interferon (IFN)-γ tumor necrosis factor-α, interleukin-6, and IFN-γ receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis
Nasim A. Ansari et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: Does ultraviolet light (UVB) radiation play a role?
A Ismail et al.
MEDICAL HYPOTHESES (2006)
Dichotomy of protective cellular immune responses to human visceral leishmaniasis
EAG Khalil et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Post-kala-azar dermal leishmaniasis
EE Zijistra et al.
LANCET INFECTIOUS DISEASES (2003)
The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features
AM Musa et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2002)
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome
K Ritmeijer et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis:: a randomised, double-blind, BCG-controlled trial in Sudan
EAG Khalil et al.
LANCET (2000)
Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis
EE Zijlstra et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani
D Wolday et al.
AIDS (2000)
The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC)
S Gasim et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
